Other languages Bio-Techne Corporation

Equities

TECH

US09073M1045

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
63.69 ^USD	+1.42%		-0.50%	-17.46%

Apr. 23	Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe	MT
Apr. 18	Deutsche Bank Adjusts Bio-Techne Price Target to $82 From $85	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio-Techne Positioned for Growth Amid Biotech Funding Recovery, UBS Says	Mar. 28
Année faste en 2023 pour les levées de fonds à l'EPFL	Feb. 12
Bio-Techne Seeks M&A	Feb. 01
Bio-Techne's Fiscal Q2 Adjusted Earnings Fall, Net Sales Rise	Feb. 01
Bio-Techne Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 01
Bio-Techne Corporation Announces to Pay A Dividend for the Quarter Ended December 31, 2023, Payable February 26, 2024	Feb. 01
Bio-Techne Corporation Sets New Standard with the Development of A Next-Generation, Protease-Free RNAscope Spatial Multiomics Workflow	Jan. 29
Bio-Techne Corporation Appoints Kim Kelderman as Chief Executive Officer Effective February 1, 2024	Jan. 05
Bio-Techne Corporation Appoints Matthew F. Mcmanus as President, Diagnostics and Genomics Segment, Effective January 8, 2024	Jan. 05
Bio-Techne Files Drug Master File With US FDA for ExCellerate GMP for Stem Cell Therapy	Dec. 20
Bio-Techne's Fiscal Q1 Adjusted Earnings Decline, Net Sales Rise	23-10-31
Bio-Techne Corporation Reports Earnings Results for the First Quarter Ended September 30, 2023	23-10-31
Bio-Techne Corporation Announces to Pay A Dividend for the Quarter Ended September 30, 2023, Will Be Payable November 24, 2023	23-10-31
Refunding relief stokes bond-led bounce	23-10-31
Bio-Techne Corporation to Present New Data Using Lunaphore's Comet Technology at the Society for Immunotherapy of Cancer's 38th Annual Meeting	23-10-25
Bio-Techne Corporation Announces Executive Changes	23-10-19
Bio-Techne Corporation Announces Chief Executive Officer Changes	23-10-19
Bio-Techne Launches Maurice Chromeleon Driver Kit for Maurice Instrument Control	23-09-26
Bio-Techne Corporation Launches the New Maurice Chromeleon Driver Kit, Which Enables Control of its Maurice? Instrument with the Thermo Scientific? Chromeleon? Chromatography Data System	23-09-26
Tekcapital's portfolio company seals joint venture	23-09-19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Bio-Techne Corporation

Equities

TECH

US09073M1045

Other languages

Filters